GBT Guerbet SA

Guerbet: Financial agenda for 2024

Guerbet: Financial agenda for 2024

Financial agenda for 2024

Villepinte, 15 January 2024: Guerbet (FR0000032526), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2024.

Publications calendar
  • 2023 ANNUAL REVENUE
February 08, 2024, after trading
  • 2023 ANNUAL RESULTS
March 20, 2024, after trading
  • 2024 1ST QUARTER REVENUE
April 25, 2024, after trading
  • ANNUAL SHAREHOLDERS’ MEETING
May 24, 2024
  • 2024 2ND QUARTER REVENUE
July 25, 2024, after trading
  • 2024 FIRST HALF RESULTS
September 25, 2024, after trading
  • 2024 3RD QUARTER REVENUE
October 24, 2024, after trading

 

 

About Guerbet

At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a leader in medical imaging worldwide, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. A pioneer in contrast media for 95 years, with more than 2,600 employees worldwide, we continuously innovate and devote 10% of our sales to research and development in four centres in France, Israel, and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €753 million in revenue in 2022.

Contacts :

Guerbet     

Jérôme Estampes, Chief Financial Officer + 33.1.45.91.50.00 /

Claire Lauvernier, Group Communication Director +33.6.79.52.11.88 /

Actifin        

Marianne Py, Financial Communication + 33.1.80.48.25.31 /

Jennifer Jullia, Media Relations +33.1.56.88.11.19 /

Attachment



EN
15/01/2024

Underlying

GBTGuerbet SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Guerbet SA

Jerôme Bodin
  • Jerôme Bodin
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
AUTN AUTONEUM HOLDING AG
IDL ID LOGISTICS GROUP
DEC JCDECAUX SA
KCO KLOECKNER & CO SE
FAGR FAGRON SA
EKI EKINOPS SA
MTU MANITOU BF SA
GBT GUERBET SA
ALLAN LANSON-BCC
SDF K+S AG
ENI ENI S.P.A.
REP REPSOL SA
INRN INTERROLL HOLDING AG
ERG ERG S.P.A.
TECN TECAN GROUP AG
KARN KARDEX HOLDING AG
SIGHT GENSIGHT BIOLOGICS SA
SEFER SERGEFERRARI GROUP SA
VIG VIENNA INSURANCE GROUP AG WIENER VERSICHERUNG GRUPPE
POST OSTERREICHISCHE POST AG
FLU FLUGHAFEN WIEN AG
VLTSA VOLTALIA
MAU ETABLISSEMENTS MAUREL & PROM SA
DUFN DUFRY AG
RUI RUBIS SCA
BP. BP P.L.C.
TFF TFF GROUP
MEDCL MEDINCELL SA
ANTIN ANTIN INFRASTRUCTURE PARTNERS
SHEL SHELL PLC
BANB BACHEM HOLDING AG
CAN CANAL+
TRIO TRIODOS BANK N.V.
AUMOV AUMOVIO
10h / 19m 10h / 19m 1 EN
Jerôme Bodin
  • Jerôme Bodin
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
AUTN AUTONEUM HOLDING AG
IDL ID LOGISTICS GROUP
DEC JCDECAUX SA
KCO KLOECKNER & CO SE
FAGR FAGRON SA
EKI EKINOPS SA
MTU MANITOU BF SA
GBT GUERBET SA
ALLAN LANSON-BCC
SDF K+S AG
ENI ENI S.P.A.
REP REPSOL SA
INRN INTERROLL HOLDING AG
ERG ERG S.P.A.
TECN TECAN GROUP AG
KARN KARDEX HOLDING AG
SIGHT GENSIGHT BIOLOGICS SA
SEFER SERGEFERRARI GROUP SA
POST OSTERREICHISCHE POST AG
FLU FLUGHAFEN WIEN AG
VLTSA VOLTALIA
MAU ETABLISSEMENTS MAUREL & PROM SA
DUFN DUFRY AG
RUI RUBIS SCA
BP. BP P.L.C.
TFF TFF GROUP
MEDCL MEDINCELL SA
ANTIN ANTIN INFRASTRUCTURE PARTNERS
SHEL SHELL PLC
BANB BACHEM HOLDING AG
CAN CANAL+
TRIO TRIODOS BANK N.V.
AUMOV AUMOVIO
10h / 33m 10h / 33m 1 FR
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
11h / 21m 11h / 21m 1 EN
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
12h / 52m 12h / 52m 1 FR
 PRESS RELEASE
Free
GBT GUERBET SA

GUERBET : Change in Guerbet’s Board of Directors.

GUERBET : Change in Guerbet’s Board of Directors. Change in Guerbet’s Board of Directors Villepinte, March 11th, 2026: Guerbet (FR0000032526 GBT), a global leader in contrast agents and solutions for medical imaging, today announced, at its Board of Directors’ meeting, the appointment of Mr. Antoine Fady as “censeur” (non-voting director) effective immediately. The appointment of Mr. Antoine Fady as a Director will be submitted for approval at the next Shareholders’ Meeting. Following this Shareholders’ Meeting, it will be proposed that the Board of Directors of Guerbet appoint Mr. Antoi...

March 11, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch